NEW YORK/LONDON, Dec 22 (Reuters) - Drug maker Shire Plc has made a new acquisition offer for peer Baxalta International Inc that is roughly in line with the latter's valuation expectations, making a deal in the coming weeks likely, people familiar with the matter said.
